Myocardial protection and financial considerations of custodiol cardioplegia in minimally invasive and open valve surgery

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery

Volumn 11, Issue 6, 2016, Pages 420-424

  Hummel, Brian W ^a   Buss, Randall W ^a   DiGiorgi, Paul L ^a   Laviano, Brittany N ^a   Yaeger, Nalani A ^a   Lucas, M Lee ^a   Comas, George M ^a  

^a Lee Memorial Health System   (United States)

Author keywords

Custodiol HTK cardioplegia; Minimally invasive valve surgery; Myocardial protection

Indexed keywords

HTK SOLUTION; TROPONIN; CARDIOPLEGIC AGENT; GLUCOSE; MANNITOL; POTASSIUM CHLORIDE; PROCAINE;

AGED; AORTA VALVE REPLACEMENT; ARTIFICIAL VENTILATION; ATRIAL FIBRILLATION; CARDIOPLEGIA; CASE CONTROL STUDY; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; HEART PROTECTION; HOSPITAL READMISSION; HUMAN; HYPERKALEMIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE CARDIAC SURGERY; MITRAL VALVE REPLACEMENT; OPEN HEART SURGERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STERNOTOMY; SURGICAL MORTALITY; THORACOTOMY; TREATMENT OUTCOME; BLOOD TRANSFUSION; ECONOMICS; HEART ARREST; HEART SURGERY; MINIMALLY INVASIVE SURGERY; MITRAL VALVE; PROCEDURES; SURGERY;

AGED; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPLEGIC SOLUTIONS; CASE-CONTROL STUDIES; COST-BENEFIT ANALYSIS; FEMALE; GLUCOSE; HEART ARREST, INDUCED; HUMANS; MALE; MANNITOL; MINIMALLY INVASIVE SURGICAL PROCEDURES; MITRAL VALVE; POTASSIUM CHLORIDE; PROCAINE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84996848248     PISSN: 15569845     EISSN: 15590879     Source Type: Journal    
DOI: 10.1097/IMI.0000000000000314     Document Type: Conference Paper

References (16)

1. Braathen B, Jeppsson A, Schersten H, et al. One single dose of histidinetryptophan- ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study. J Thorac Cardiovasc Surg. 2011;141:995-1001.
2. Takeuchi K, Buenaventura P, Cao-Danh H, et al. Improved protection of the hypertrophied left ventricle by histidine-containing cardioplegia. Circulation. 1995;92:II395-II399.
3. Careaga G, Salazar D, Tellez S, Sánchez O, Borrayo O, Argüero R. Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients. Arch Med Resear. 2001;32:296-299.
4. Savini C, Camurri N, Castelli A, et al. Myocardial protection using HTK solution inminimally invasive mitral valve surgery. Heart Surg Forum. 2005;8: E25-E27.
5. Scrascia G, Guida P, Rotunno C, et al. Myocardial protection during aortic surgery: comparison between Bretschneider-HTK and cold blood cardioplegia. Perfusion. 2011;26:427-433.
6. Iribarne A, Easterwood R, Russo M, et al. A minimally invasive approach is more cost-effective than a traditional sternotomy approach for mitral valve surgery. J Thorac Cardiovasc Surg. 2011;142:1507-1514.
7. Savini C, Murana G, Di Eusanio M, et al. Safety of single-dose histidinetryptophan- ketoglutarate cardioplegia duringminimally invasive mitral valve surgery. Innovations. 2014;9:416-420.
8. Matzelle S, Murphy M, Weightman W, Gibbs NM, Edelman JJ, Passage J. Minimally invasive mitral valve surgery using single dose antegrade custodiol cardioplegia. Heart Lung Circ. 2014;23:863-868.
9. Liu J, Feng Z, Zhao J, Li B, Long C. The myocardial protection of HTK cardioplegic solution on the long-term ischemic period in pediatric heart surgery. ASAIO J. 2008;54:470-473.
10. Chambers DJ. Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg. 2003;75:S661-S666.
11. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg. 1980;28: 295-302.
12. Hearse DJ, Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res. 1992;26:101-108.
13. Fridell JA, Mangus RS, Tector AJ. Clinical experience with histidinetryptophan- ketoglutarate solution in abdominal organ preservation: a review of recent literature. Clin Transplant. 2009;23:305-312.
14. Beyersdorf F, Krause E, Sarai K, et al. Clinical evaluation of hypothermic ventricular fibrillation, multi-dose blood cardioplegia, and single-dose Bretschneider cardioplegia in coronary surgery. Thorac Cardiovasc Surg. 1990;38:20-29.
15. Edelman J, Seco M, Dunne B, et al. Custodiol for myocardial protection and preservation: a systematic review. Ann Cardiothorac Surg. 2013;2:717-728.
16. Murrah CP, Ferguson ER, Spruell RD, Holman WL. Arrest duration influences postcardioplegic electrophysiologic recovery and reperfusion arrhythmias. Ann Thorac Surg. 1998;65:1003-1008.